1
|
Bellera CL, Balcazar DE, Alberca L, Labriola CA, Talevi A, Carrillo C. Identification of levothyroxine antichagasic activity through computer-aided drug repurposing. ScientificWorldJournal 2014; 2014:279618. [PMID: 24592161 PMCID: PMC3926237 DOI: 10.1155/2014/279618] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2013] [Accepted: 11/13/2013] [Indexed: 12/12/2022] Open
Abstract
Cruzipain (Cz) is the major cysteine protease of the protozoan Trypanosoma cruzi, etiological agent of Chagas disease. A conformation-independent classifier capable of identifying Cz inhibitors was derived from a 163-compound dataset and later applied in a virtual screening campaign on the DrugBank database, which compiles FDA-approved and investigational drugs. 54 approved drugs were selected as candidates, 3 of which were acquired and tested on Cz and T. cruzi epimastigotes proliferation. Among them, levothyroxine, traditionally used in hormone replacement therapy in patients with hypothyroidism, showed dose-dependent inhibition of Cz and antiproliferative activity on the parasite.
Collapse
Affiliation(s)
- Carolina L. Bellera
- Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata, 47 y 115, La Plata (B1900AJI) Buenos Aires, Argentina
| | - Darío E. Balcazar
- Instituto de Ciencia y Tecnología Dr. César Milstein (ICT Milstein), Argentinean National Council of Scientific and Technical Research (CONICET), Saladillo 2468, Ciudad Autónoma de Buenos Aires (C1440FFX), Argentina
| | - Lucas Alberca
- Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata, 47 y 115, La Plata (B1900AJI) Buenos Aires, Argentina
| | - Carlos A. Labriola
- Instituto de Investigaciones Bioquímicas de Buenos Aires, Argentinean National Council of Scientific and Technical Research (CONICET), Avenida Patricias Argentinas 435, Ciudad Autónoma de Buenos Aires (C1405BWE), Argentina
| | - Alan Talevi
- Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata, 47 y 115, La Plata (B1900AJI) Buenos Aires, Argentina
| | - Carolina Carrillo
- Instituto de Ciencia y Tecnología Dr. César Milstein (ICT Milstein), Argentinean National Council of Scientific and Technical Research (CONICET), Saladillo 2468, Ciudad Autónoma de Buenos Aires (C1440FFX), Argentina
| |
Collapse
|
2
|
Rodrigues GC, Feijó DF, Bozza MT, Pan P, Vullo D, Parkkila S, Supuran CT, Capasso C, Aguiar AP, Vermelho AB. Design, Synthesis, and Evaluation of Hydroxamic Acid Derivatives as Promising Agents for the Management of Chagas Disease. J Med Chem 2013; 57:298-308. [DOI: 10.1021/jm400902y] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Affiliation(s)
- Giseli Capaci Rodrigues
- Laboratório de Síntese Orgânica,
Departamento de Química, Instituto Militar de Engenharia, IME, Rio
de Janeiro, Brasil
- Laboratório Proteases
de Microrganismos, Departamento de Microbiologia, Instituto de Microbiologia Paulo de Góes, IMPG, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brasil
- Escola de
Ciência e Tecnologia e Programa de Pós-Graduação
em Ensino das Ciências, Universidade do Grande Rio, Unigranrio, Duque
de Caxias, Rio de Janeiro, Brasil
| | - Daniel Ferreira Feijó
- Laboratório de Inflamação e Imunidade,
Departamento de Imunologia, Instituto de Microbiologia Paulo de Góes, IMPPG, Universidade Federal do Rio de Janeiro, UFRJ, Rio
de Janeiro, Brasil
| | - Marcelo Torres Bozza
- Laboratório de Inflamação e Imunidade,
Departamento de Imunologia, Instituto de Microbiologia Paulo de Góes, IMPPG, Universidade Federal do Rio de Janeiro, UFRJ, Rio
de Janeiro, Brasil
| | - Peiwen Pan
- Institute of Biomedical
Technology, Fimlab Ltd., School of Medicine and BioMediTech, University of Tampere and Tampere University Hospital, Medisiinarinkatu 3, 33520 Tampere, Finland
| | - Daniela Vullo
- Laboratorio di Chimica Bioinorganica, Universita degli Studi di Firenze, Via della Lastruccia 3, Rm. 188, Polo Scientifico, 50019 Sesto Fiorentino, Florence, Italy
| | - Seppo Parkkila
- Institute of Biomedical
Technology, Fimlab Ltd., School of Medicine and BioMediTech, University of Tampere and Tampere University Hospital, Medisiinarinkatu 3, 33520 Tampere, Finland
| | - Claudiu T. Supuran
- Laboratorio di Chimica Bioinorganica, Universita degli Studi di Firenze, Via della Lastruccia 3, Rm. 188, Polo Scientifico, 50019 Sesto Fiorentino, Florence, Italy
- Dipartimento NEIROFARBA, Sezione di Scienze
Farmaceutiche, Universita degli Studi di Firenze, Via Ugo Schiff
6, 50019 Sesto Fiorentino, Florence, Italy
| | - Clemente Capasso
- Istituto di Biochimica delle Proteine, CNR, Via P. Castellino 111, 80131 Napoli, Italy
| | - Alcino Palermo Aguiar
- Laboratório de Síntese Orgânica,
Departamento de Química, Instituto Militar de Engenharia, IME, Rio
de Janeiro, Brasil
| | - Alane Beatriz Vermelho
- Laboratório Proteases
de Microrganismos, Departamento de Microbiologia, Instituto de Microbiologia Paulo de Góes, IMPG, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brasil
- Biotecnologia −
BIOINOVAR: Unidade de Bioenergia, Biocatalise e Bioprodutos, Instituto de Microbiologia Paulo de Góes, IMPG, Universidade Federal do Rio de Janeiro, UFRJ, Rio de Janeiro, Brasil
| |
Collapse
|
3
|
Bellera CL, Balcazar DE, Alberca L, Labriola CA, Talevi A, Carrillo C. Application of computer-aided drug repurposing in the search of new cruzipain inhibitors: discovery of amiodarone and bromocriptine inhibitory effects. J Chem Inf Model 2013; 53:2402-8. [PMID: 23906322 DOI: 10.1021/ci400284v] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023]
Abstract
Cruzipain (Cz) is the major cystein protease of the protozoan Trypanosoma cruzi , etiological agent of Chagas disease. From a 163 compound data set, a 2D-classifier capable of identifying Cz inhibitors was obtained and applied in a virtual screening campaign on the DrugBank database, which compiles FDA-approved and investigational drugs. Fifty-four approved drugs were selected as candidates, four of which were acquired and tested on Cz and T. cruzi epimastigotes. Among them, the antiparkinsonian and antidiabetic drug bromocriptine and the antiarrhythmic amiodarone showed dose-dependent inhibition of Cz and antiproliferative activity on the parasite.
Collapse
Affiliation(s)
- Carolina L Bellera
- Medicinal Chemistry, Department of Biological Sciences, Faculty of Exact Sciences, National University of La Plata , 47 y 115, La Plata (B1900AJI), Buenos Aires, Argentina
| | | | | | | | | | | |
Collapse
|